insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
$120.29
arrow_upward
+1.34%(+1.59) 1D
Oct 12, 2:07:33 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$118.70
High
$121.60
Low
$118.36
Mkt. cap
5.47B
Avg. vol.
668.91K
Volume
434.70K
P/E ratio
58.67
52-wk high
$121.60
52-wk low
$48.55
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$118.70
High
$121.60
Low
$118.36
Mkt. cap
5.47B
Avg. vol.
668.91K
Volume
434.70K
P/E ratio
58.67
52-wk high
$121.60
52-wk low
$48.55
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
The Motley Fool
·
22 minutes ago
Not Sandisk, Not Intel. This Stock Will Lead the S&P 500 Next Year
JournalArta
·
23 minutes ago
Panmure Liberum Sees S&P 500 Falling: What to Know
Curzio Research
·
46 minutes ago
A silent bear market hiding under the S&P 500’s record high
TradingView
·
1 hour ago
S&P 500 expected to see 25% EPS growth as earnings kick off
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com